Late Subconjunctival Emphysema in an Unrepaired Orbital Floor Fracture

por Boyer, Emanuel F, Filutowski, Oliver, Slonim, Charles
Publicado 2022

Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials

por Slonim, Charles B., Foster, Shane, Jaros, Mark, Kannarr, Shane R., Korenfeld, Michael S., Smyth-Medina, Robert, Wirta, David L.
Publicado 2020

Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results

por Bacharach, Jason, Wirta, David L, Smyth-Medina, Robert, Korenfeld, Michael S, Kannarr, Shane R, Foster, Shane, J Jaros, Mark, Slonim, Charles B
Publicado 2021

Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials

por Wirta, David L, Korenfeld, Michael S, Foster, Shane, Smyth-Medina, Robert, Bacharach, Jason, Kannarr, Shane R, Jaros, Mark J, Slonim, Charles B
Publicado 2021

Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial

por Pepose, Jay S, Hartman, Paul J, DuBiner, Harvey B, Abrams, Marc A, Smyth-Medina, Robert J, Moroi, Sayoko E, Meyer, Alan R, Sooch, Mina P, Jaber, Reda M, Charizanis, Konstantinos, Klapman, Seth A, Amin, Arin T, Yousif, Jonah E, Lazar, Eliot S, Karpecki, Paul M, Slonim, Charles B, McDonald, Marguerite B
Publicado 2021